Photo:
shformacion.es
Apr 19, 2026, 13:52
David Montani: SOX17 Variants and Their Broader Impact in Pulmonary Arterial Hypertension
David Montani, Professor of Pulmonology and Hospital Practitioner at Paris-Saclay University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in International Journal of Cardiology:
“Happy to share this editorial, written with Thomas Lacoste-Palasset, Julien Grynblat, Grégoire Ruffenach, and Florence Coulet: ‘SOX17 variants in pulmonary arterial hypertension and beyond: When genetics redefines the phenotype’.”
Title: SOX17 variants in pulmonary arterial hypertension and beyond: When genetics redefines the phenotype
Authors: Thomas Lacoste-Palasset, Julien Grynblat, Gregoire Ruffenach, Florence Coulet, David Montani
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 8, 2026, 02:49Jared Rice: High Platelets, Low Clot Risk? – What Makes Neonatal Platelets Different in Sepsis
-
Sep 8, 2026, 02:46Rasha E.: Exploring Polycythemia Vera: Beyond the Hematocrit
-
Sep 8, 2026, 02:35Ahmet Davut Aksu: Plasminogen Supplementation Enhances Alteplase Efficacy in Systemic Embolization Model
-
Sep 7, 2026, 23:56Abdel Gaffar Mohammed: Treatment Approaches for Different Types of TMA
-
Sep 7, 2026, 18:36Richard Kollen: Preventing Deep Vein Thrombosis During Long Flights
-
Sep 7, 2026, 18:34Mahmoud Hashem: Apixaban – Doses According to the Reason for Use
-
Sep 7, 2026, 18:31Julian P. Villacastin: LAAC as a Treatment Option When Long-Term Anticoagulation Is Problematic
-
Sep 7, 2026, 18:29Geoff Stooke: How Hemophilia Led the Massie Family to the Romanovs and Ronald Reagan
-
Sep 7, 2026, 18:27Sam Mbunya: September is Sickle Cell Awareness Month